These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
2. Effect of erythromycin and itraconazole on the pharmacokinetics of oral lignocaine. Isohanni MH; Neuvonen PJ; Olkkola KT Pharmacol Toxicol; 1999 Mar; 84(3):143-6. PubMed ID: 10193676 [TBL] [Abstract][Full Text] [Related]
3. Simvastatin but not pravastatin is very susceptible to interaction with the CYP3A4 inhibitor itraconazole. Neuvonen PJ; Kantola T; Kivistö KT Clin Pharmacol Ther; 1998 Mar; 63(3):332-41. PubMed ID: 9542477 [TBL] [Abstract][Full Text] [Related]
4. The cytochrome P450 3A4 inhibitor itraconazole markedly increases the plasma concentrations of dexamethasone and enhances its adrenal-suppressant effect. Varis T; Kivistö KT; Backman JT; Neuvonen PJ Clin Pharmacol Ther; 2000 Nov; 68(5):487-94. PubMed ID: 11103751 [TBL] [Abstract][Full Text] [Related]
5. Plasma concentrations and effects of oral methylprednisolone are considerably increased by itraconazole. Varis T; Kaukonen KM; Kivistö KT; Neuvonen PJ Clin Pharmacol Ther; 1998 Oct; 64(4):363-8. PubMed ID: 9797792 [TBL] [Abstract][Full Text] [Related]
6. Effect of erythromycin and itraconazole on the pharmacokinetics of intravenous lignocaine. Isohanni MH; Neuvonen PJ; Palkama VJ; Olkkola KT Eur J Clin Pharmacol; 1998 Sep; 54(7):561-5. PubMed ID: 9832299 [TBL] [Abstract][Full Text] [Related]
7. A kinetic and dynamic study of oral alprazolam with and without erythromycin in humans: in vivo evidence for the involvement of CYP3A4 in alprazolam metabolism. Yasui N; Otani K; Kaneko S; Ohkubo T; Osanai T; Sugawara K; Chiba K; Ishizaki T Clin Pharmacol Ther; 1996 May; 59(5):514-9. PubMed ID: 8646822 [TBL] [Abstract][Full Text] [Related]
10. No effect of itraconazole on the single oral dose pharmacokinetics and pharmacodynamics of estazolam. Otsuji Y; Okuyama N; Aoshima T; Fukasawa T; Kato K; Gerstenberg G; Miura M; Ohkubo T; Sugawara K; Otani K Ther Drug Monit; 2002 Jun; 24(3):375-8. PubMed ID: 12021628 [TBL] [Abstract][Full Text] [Related]
11. Itraconazole, gemfibrozil and their combination markedly raise the plasma concentrations of loperamide. Niemi M; Tornio A; Pasanen MK; Fredrikson H; Neuvonen PJ; Backman JT Eur J Clin Pharmacol; 2006 Jun; 62(6):463-72. PubMed ID: 16758263 [TBL] [Abstract][Full Text] [Related]
12. Fluconazole but not itraconazole decreases the metabolism of losartan to E-3174. Kaukonen KM; Olkkola KT; Neuvonen PJ Eur J Clin Pharmacol; 1998 Feb; 53(6):445-9. PubMed ID: 9551703 [TBL] [Abstract][Full Text] [Related]
13. Itraconazole drastically increases plasma concentrations of lovastatin and lovastatin acid. Neuvonen PJ; Jalava KM Clin Pharmacol Ther; 1996 Jul; 60(1):54-61. PubMed ID: 8689812 [TBL] [Abstract][Full Text] [Related]
14. Mibefradil but not isradipine substantially elevates the plasma concentrations of the CYP3A4 substrate triazolam. Backman JT; Wang JS; Wen X; Kivistö KT; Neuvonen PJ Clin Pharmacol Ther; 1999 Oct; 66(4):401-7. PubMed ID: 10546924 [TBL] [Abstract][Full Text] [Related]
15. Interactions of buspirone with itraconazole and rifampicin: effects on the pharmacokinetics of the active 1-(2-pyrimidinyl)-piperazine metabolite of buspirone. Kivistö KT; Lamberg TS; Neuvonen PJ Pharmacol Toxicol; 1999 Feb; 84(2):94-7. PubMed ID: 10068153 [TBL] [Abstract][Full Text] [Related]
16. Plasma concentrations of inhaled budesonide and its effects on plasma cortisol are increased by the cytochrome P4503A4 inhibitor itraconazole. Raaska K; Niemi M; Neuvonen M; Neuvonen PJ; Kivistö KT Clin Pharmacol Ther; 2002 Oct; 72(4):362-9. PubMed ID: 12386638 [TBL] [Abstract][Full Text] [Related]
17. Effect of itraconazole on the pharmacokinetics of atorvastatin. Kantola T; Kivistö KT; Neuvonen PJ Clin Pharmacol Ther; 1998 Jul; 64(1):58-65. PubMed ID: 9695720 [TBL] [Abstract][Full Text] [Related]